ReP USP - Resultado da busca

Artigo de periodico
Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas (2023)
Sousa, Graziella Ribeiro de ; Salomão, Karina B.; Nagano, Luís Fernando Peinado ; Riemondy, Kent A.; Chagas, Pablo Shimaoka ; Veronez, Luciana Chain ; Saggioro, Fabiano Pinto ; Marie, Suely Kazue Nagahashi ; Yunes, José A.; Cardinalli, Izilda Aparecida; Brandalise, Silvia Regina ; Queiroz, Rosane Gomes de Paula; Scrideli, Carlos Alberto ; Donson, Andrew M.; Foreman, Nicholas K.; Tone, Luiz Gonzaga ; Valera, Elvis Terci
Source: Cancer Gene Therapy. Unidades: FMRP, FM, FCFRP
Subjects: NEOPLASIAS CEREBRAIS, PERFILAÇÃO DA EXPRESSÃO GÊNICA, PROGNÓSTICO, FATORES DE TRANSCRIÇÃO, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Graziella Ribeiro de et al. Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas. Cancer Gene Therapy, v. 30, p. 1105-1113, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41417-023-00616-z. Acesso em: 31 out. 2024.
APA
Sousa, G. R. de, Salomão, K. B., Nagano, L. F. P., Riemondy, K. A., Chagas, P. S., Veronez, L. C., et al. (2023). Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas. Cancer Gene Therapy, 30, 1105-1113. doi:10.1038/s41417-023-00616-z
NLM
Sousa GR de, Salomão KB, Nagano LFP, Riemondy KA, Chagas PS, Veronez LC, Saggioro FP, Marie SKN, Yunes JA, Cardinalli IA, Brandalise SR, Queiroz RG de P, Scrideli CA, Donson AM, Foreman NK, Tone LG, Valera ET. Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas [Internet]. Cancer Gene Therapy. 2023 ; 30 1105-1113.[citado 2024 out. 31 ] Available from: https://doi.org/10.1038/s41417-023-00616-z
Vancouver
Sousa GR de, Salomão KB, Nagano LFP, Riemondy KA, Chagas PS, Veronez LC, Saggioro FP, Marie SKN, Yunes JA, Cardinalli IA, Brandalise SR, Queiroz RG de P, Scrideli CA, Donson AM, Foreman NK, Tone LG, Valera ET. Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas [Internet]. Cancer Gene Therapy. 2023 ; 30 1105-1113.[citado 2024 out. 31 ] Available from: https://doi.org/10.1038/s41417-023-00616-z
Artigo de periodico
High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population (2023)
Moreno, Daniel Antunes; Bonatelli, Murilo; Antoniazzi, Augusto Perazzolo; Paula, Flávia Escremim de; Leal, Leticia Ferro; Garcia, Felipe Antônio de Oliveira; Paula, André Escremim de; Teixeira, Gustavo Ramos; Santana, Iara Viana Vidigal; Saggioro, Fabiano Pinto ; Neder, Luciano ; Valera, Elvis Terci ; Scrideli, Carlos Alberto ; Stavale, João; Malheiros, Suzana Maria Fleury; Lima, Matheus; Hajj, Glaucia Noeli Maroso; Garcia-Rivello, Hernan; Christiansen, Silvia; Nunes, Susana; Gil-da-Costa, Maria João; Pinheiro, Jorge; Martins, Flavia Delgado; Junior, Carlos Almeida; Mançano, Bruna Minniti; Reis, Rui Manuel
Source: Frontiers in Oncology. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, MEDULOBLASTOMA, HEREDITARIEDADE, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO, Daniel Antunes et al. High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population. Frontiers in Oncology, v. 13, 2023Tradução . . Disponível em: https://doi.org/10.3389/fonc.2023.1237170. Acesso em: 31 out. 2024.
APA
Moreno, D. A., Bonatelli, M., Antoniazzi, A. P., Paula, F. E. de, Leal, L. F., Garcia, F. A. de O., et al. (2023). High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population. Frontiers in Oncology, 13. doi:10.3389/fonc.2023.1237170
NLM
Moreno DA, Bonatelli M, Antoniazzi AP, Paula FE de, Leal LF, Garcia FA de O, Paula AE de, Teixeira GR, Santana IVV, Saggioro FP, Neder L, Valera ET, Scrideli CA, Stavale J, Malheiros SMF, Lima M, Hajj GNM, Garcia-Rivello H, Christiansen S, Nunes S, Gil-da-Costa MJ, Pinheiro J, Martins FD, Junior CA, Mançano BM, Reis RM. High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population [Internet]. Frontiers in Oncology. 2023 ;13[citado 2024 out. 31 ] Available from: https://doi.org/10.3389/fonc.2023.1237170
Vancouver
Moreno DA, Bonatelli M, Antoniazzi AP, Paula FE de, Leal LF, Garcia FA de O, Paula AE de, Teixeira GR, Santana IVV, Saggioro FP, Neder L, Valera ET, Scrideli CA, Stavale J, Malheiros SMF, Lima M, Hajj GNM, Garcia-Rivello H, Christiansen S, Nunes S, Gil-da-Costa MJ, Pinheiro J, Martins FD, Junior CA, Mançano BM, Reis RM. High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population [Internet]. Frontiers in Oncology. 2023 ;13[citado 2024 out. 31 ] Available from: https://doi.org/10.3389/fonc.2023.1237170
Artigo de periodico
Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma (2023)
Magalhaes, Taciani de Almeida; Cruzeiro, Gustavo Alencastro Veiga; Sousa, Graziella Ribeiro de; Saggioro, Fabiano Pinto ; Marie, Suely Kazue Nagahashi ; Shinjo, Sueli Mieko Oba ; Queiroz, Rosane Gomes de Paula; Scrideli, Carlos Alberto ; Tone, Luiz Gonzaga ; Valera, Elvis Terci
Source: Neuro-oncology. Unidades: FM, FMRP
Subjects: MEDULOBLASTOMA, NEOPLASIAS DE CABEÇA E PESCOÇO, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAGALHAES, Taciani de Almeida et al. Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma. Neuro-oncology, v. 25, n. 1, p. 185-198, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52983. Acesso em: 31 out. 2024.
APA
Magalhaes, T. de A., Cruzeiro, G. A. V., Sousa, G. R. de, Saggioro, F. P., Marie, S. K. N., Shinjo, S. M. O., et al. (2023). Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma. Neuro-oncology, 25( 1), 185-198. doi:10.1093/neuonc/noac147
NLM
Magalhaes T de A, Cruzeiro GAV, Sousa GR de, Saggioro FP, Marie SKN, Shinjo SMO, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma [Internet]. Neuro-oncology. 2023 ; 25( 1): 185-198.[citado 2024 out. 31 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52983
Vancouver
Magalhaes T de A, Cruzeiro GAV, Sousa GR de, Saggioro FP, Marie SKN, Shinjo SMO, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma [Internet]. Neuro-oncology. 2023 ; 25( 1): 185-198.[citado 2024 out. 31 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52983
Artigo de periodico
Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells (2023)
Chagas, Pablo Shimaoka ; Veronez, Luciana Chain ; Sousa, Graziella Ribeiro de ; Cruzeiro, Gustavo Alencastro Veiga ; Correa, Carolina Alves Pereira ; Saggioro, Fabiano Pinto ; Queiroz, Rosane Gomes de Paula; Marie, Suely Kazue Nagahashi ; Brandalise, Silvia Regina ; Cardinalli, Izilda Aparecida; Yunes, Jose Andres ; Carlotti Júnior, Carlos Gilberto ; Machado, Hélio Rubens ; Santos, Marcelo Volpon ; Scrideli, Carlos Alberto ; Tone, Luiz Gonzaga ; Valera, Elvis Terci
Source: Human cell. Unidades: FM, FMRP
Subjects: MEDULOBLASTOMA, BIOMARCADORES, GENÉTICA, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAGAS, Pablo Shimaoka et al. Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells. Human cell, v. 36, n. 6, p. 2129-2139, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57460. Acesso em: 31 out. 2024.
APA
Chagas, P. S., Veronez, L. C., Sousa, G. R. de, Cruzeiro, G. A. V., Correa, C. A. P., Saggioro, F. P., et al. (2023). Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells. Human cell, 36( 6), 2129-2139. doi:10.1007/s13577-023-00954-y
NLM
Chagas PS, Veronez LC, Sousa GR de, Cruzeiro GAV, Correa CAP, Saggioro FP, Queiroz RG de P, Marie SKN, Brandalise SR, Cardinalli IA, Yunes JA, Carlotti Júnior CG, Machado HR, Santos MV, Scrideli CA, Tone LG, Valera ET. Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells [Internet]. Human cell. 2023 ; 36( 6): 2129-2139.[citado 2024 out. 31 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57460
Vancouver
Chagas PS, Veronez LC, Sousa GR de, Cruzeiro GAV, Correa CAP, Saggioro FP, Queiroz RG de P, Marie SKN, Brandalise SR, Cardinalli IA, Yunes JA, Carlotti Júnior CG, Machado HR, Santos MV, Scrideli CA, Tone LG, Valera ET. Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells [Internet]. Human cell. 2023 ; 36( 6): 2129-2139.[citado 2024 out. 31 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57460
Artigo de periodico
Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma (2023)
Silva, Andréa Martins da; Baroni, Mirella ; Salomão, Karina Bezerra ; Chagas, Pablo Ferreira das ; Silva, Ricardo Bonfim; Geron, Lenisa; Cruzeiro, Gustavo Alencastro Veiga ; Silva Junior, Wilson Araújo da ; Correa, Carolina Alves Pereira ; Carlotti Júnior, Carlos Gilberto ; Queiroz, Rosane Gomes de Paula; Marie, Suely Kazue Nagahashi ; Brandalise, Silvia Regina ; Yunes, Jose Andres ; Scrideli, Carlos Alberto ; Valera, Elvis Terci ; Tone, Luiz Gonzaga
Source: CELLULAR AND MOLECULAR NEUROBIOLOGY. Unidades: FMRP, FM
Subjects: MEDULOBLASTOMA, BIOMARCADORES, CRIANÇAS, NEOPLASIAS CEREBRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Andréa Martins da et al. Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma. CELLULAR AND MOLECULAR NEUROBIOLOGY, v. 43, n. 2, p. 813-826, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57968. Acesso em: 31 out. 2024.
APA
Silva, A. M. da, Baroni, M., Salomão, K. B., Chagas, P. F. das, Silva, R. B., Geron, L., et al. (2023). Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma. CELLULAR AND MOLECULAR NEUROBIOLOGY, 43( 2), 813-826. doi:10.1007/s10571-022-01217-4
NLM
Silva AM da, Baroni M, Salomão KB, Chagas PF das, Silva RB, Geron L, Cruzeiro GAV, Silva Junior WA da, Correa CAP, Carlotti Júnior CG, Queiroz RG de P, Marie SKN, Brandalise SR, Yunes JA, Scrideli CA, Valera ET, Tone LG. Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma [Internet]. CELLULAR AND MOLECULAR NEUROBIOLOGY. 2023 ; 43( 2): 813-826.[citado 2024 out. 31 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57968
Vancouver
Silva AM da, Baroni M, Salomão KB, Chagas PF das, Silva RB, Geron L, Cruzeiro GAV, Silva Junior WA da, Correa CAP, Carlotti Júnior CG, Queiroz RG de P, Marie SKN, Brandalise SR, Yunes JA, Scrideli CA, Valera ET, Tone LG. Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma [Internet]. CELLULAR AND MOLECULAR NEUROBIOLOGY. 2023 ; 43( 2): 813-826.[citado 2024 out. 31 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57968
Artigo de periodico
MicroRNA expression profile predicts prognosis of pediatric adrenocortical tumors (2022)
Veronez, Luciana Chain ; Fedatto, Paola Fernanda ; Correa, Carolina Alves Pereira ; Lira, Régia Caroline Peixoto ; Baroni, Mirella; Silva, Keteryne Rodrigues da ; Santos, Paula; Antonio, David Santos Marco; Queiroz, Rosane de Paula Silva; Antonini, Sonir Roberto Rauber ; Tucci Júnior, Silvio ; Neder, Luciano ; Yunes, José Andres; Brandalise, Silvia Regina; Panepucci, Rodrigo Alexandre; Tone, Luiz Gonzaga ; Scrideli, Carlos Alberto
Source: Pediatric Blood & Cancer. Unidades: FMRP, FCFRP
Subjects: PERFILAÇÃO DA EXPRESSÃO GÊNICA, MICRORNAS, NEOPLASIAS DAS GLÂNDULAS SUPRARRENAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VERONEZ, Luciana Chain et al. MicroRNA expression profile predicts prognosis of pediatric adrenocortical tumors. Pediatric Blood & Cancer, v. 69, n. 7, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1002/pbc.29553. Acesso em: 31 out. 2024.
APA
Veronez, L. C., Fedatto, P. F., Correa, C. A. P., Lira, R. C. P., Baroni, M., Silva, K. R. da, et al. (2022). MicroRNA expression profile predicts prognosis of pediatric adrenocortical tumors. Pediatric Blood & Cancer, 69( 7), 1-11. doi:10.1002/pbc.29553
NLM
Veronez LC, Fedatto PF, Correa CAP, Lira RCP, Baroni M, Silva KR da, Santos P, Antonio DSM, Queiroz R de PS, Antonini SRR, Tucci Júnior S, Neder L, Yunes JA, Brandalise SR, Panepucci RA, Tone LG, Scrideli CA. MicroRNA expression profile predicts prognosis of pediatric adrenocortical tumors [Internet]. Pediatric Blood & Cancer. 2022 ; 69( 7): 1-11.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.29553
Vancouver
Veronez LC, Fedatto PF, Correa CAP, Lira RCP, Baroni M, Silva KR da, Santos P, Antonio DSM, Queiroz R de PS, Antonini SRR, Tucci Júnior S, Neder L, Yunes JA, Brandalise SR, Panepucci RA, Tone LG, Scrideli CA. MicroRNA expression profile predicts prognosis of pediatric adrenocortical tumors [Internet]. Pediatric Blood & Cancer. 2022 ; 69( 7): 1-11.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.29553
Artigo de periodico
Vitamin D receptor hypermethylation as a biomarker for pediatric adrenocortical tumors (2022)
Bueno, Ana Carolina; Stecchini, Mônica Freire ; Marrero Gutierrez, Junier; More, Candy Christie Bellido ; Leal, Letícia Ferro; Gomes, Debora Cristiane; Lima Neto, Daniel Ferreira de; Brandalise, Silvia Regina; Cardinalli, Izilda Aparecida; Yunes, Jose Andres; Junqueira, Thaís; Scrideli, Carlos Alberto ; Molina, Carlos Augusto Fernandes ; Ramalho, Fernando Silva ; Tucci Júnior, Silvio ; Coeli-Lacchini, Fernanda Borchers; Moreira, Ayrton Custódio; Ramalho, Leandra Naira Zambelli ; Vêncio, Ricardo Zorzetto Nicoliello ; Castro, Margaret de ; Antonini, Sonir Roberto Rauber
Source: European Journal of Endocrinology. Unidades: FMRP, FFCLRP
Subjects: BIOMARCADORES, CÓRTEX ADRENAL, METILAÇÃO, NEOPLASIAS, PEDIATRIA, RECEPTORES, VITAMINA D
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUENO, Ana Carolina et al. Vitamin D receptor hypermethylation as a biomarker for pediatric adrenocortical tumors. European Journal of Endocrinology, v. 186, n. 5, p. 573-585, 2022Tradução . . Disponível em: https://doi.org/10.1530/EJE-21-0879. Acesso em: 31 out. 2024.
APA
Bueno, A. C., Stecchini, M. F., Marrero Gutierrez, J., More, C. C. B., Leal, L. F., Gomes, D. C., et al. (2022). Vitamin D receptor hypermethylation as a biomarker for pediatric adrenocortical tumors. European Journal of Endocrinology, 186( 5), 573-585. doi:10.1530/EJE-21-0879
NLM
Bueno AC, Stecchini MF, Marrero Gutierrez J, More CCB, Leal LF, Gomes DC, Lima Neto DF de, Brandalise SR, Cardinalli IA, Yunes JA, Junqueira T, Scrideli CA, Molina CAF, Ramalho FS, Tucci Júnior S, Coeli-Lacchini FB, Moreira AC, Ramalho LNZ, Vêncio RZN, Castro M de, Antonini SRR. Vitamin D receptor hypermethylation as a biomarker for pediatric adrenocortical tumors [Internet]. European Journal of Endocrinology. 2022 ; 186( 5): 573-585.[citado 2024 out. 31 ] Available from: https://doi.org/10.1530/EJE-21-0879
Vancouver
Bueno AC, Stecchini MF, Marrero Gutierrez J, More CCB, Leal LF, Gomes DC, Lima Neto DF de, Brandalise SR, Cardinalli IA, Yunes JA, Junqueira T, Scrideli CA, Molina CAF, Ramalho FS, Tucci Júnior S, Coeli-Lacchini FB, Moreira AC, Ramalho LNZ, Vêncio RZN, Castro M de, Antonini SRR. Vitamin D receptor hypermethylation as a biomarker for pediatric adrenocortical tumors [Internet]. European Journal of Endocrinology. 2022 ; 186( 5): 573-585.[citado 2024 out. 31 ] Available from: https://doi.org/10.1530/EJE-21-0879
Artigo de periodico
MicroRNA expression profile predicts prognosis of pediatric adrenocortical tumors (2022)
Veronez, Luciana Chain ; Fedatto, Paola Fernanda; Correa, Carolina Alves Pereira ; Lira, Régia Caroline Peixoto; Baroni, Mirella; Silva, Keteryne Rodrigues da ; Santos, Paula; Antonio, David Santos Marco; Queiroz, Rosane de Paula Silva; Antonini, Sonir Roberto Rauber ; Tucci Júnior, Silvio ; Neder, Luciano ; Yunes, Jose Andres ; Brandalise, Silvia Regina; Panepucci, Rodrigo Alexandre ; Tone, Luiz Gonzaga ; Scrideli, Carlos Alberto
Source: Pediatric Blood & Cancer. Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS, CRIANÇAS, MICRORNAS, BIOMARCADORES, PERFILAÇÃO DA EXPRESSÃO GÊNICA, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VERONEZ, Luciana Chain et al. MicroRNA expression profile predicts prognosis of pediatric adrenocortical tumors. Pediatric Blood & Cancer, v. 69, n. 7, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1002/pbc.29553. Acesso em: 31 out. 2024.
APA
Veronez, L. C., Fedatto, P. F., Correa, C. A. P., Lira, R. C. P., Baroni, M., Silva, K. R. da, et al. (2022). MicroRNA expression profile predicts prognosis of pediatric adrenocortical tumors. Pediatric Blood & Cancer, 69( 7), 1-11. doi:10.1002/pbc.29553
NLM
Veronez LC, Fedatto PF, Correa CAP, Lira RCP, Baroni M, Silva KR da, Santos P, Antonio DSM, Queiroz R de PS, Antonini SRR, Tucci Júnior S, Neder L, Yunes JA, Brandalise SR, Panepucci RA, Tone LG, Scrideli CA. MicroRNA expression profile predicts prognosis of pediatric adrenocortical tumors [Internet]. Pediatric Blood & Cancer. 2022 ; 69( 7): 1-11.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.29553
Vancouver
Veronez LC, Fedatto PF, Correa CAP, Lira RCP, Baroni M, Silva KR da, Santos P, Antonio DSM, Queiroz R de PS, Antonini SRR, Tucci Júnior S, Neder L, Yunes JA, Brandalise SR, Panepucci RA, Tone LG, Scrideli CA. MicroRNA expression profile predicts prognosis of pediatric adrenocortical tumors [Internet]. Pediatric Blood & Cancer. 2022 ; 69( 7): 1-11.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.29553
Artigo de periodico
MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways (2021)
Veronez, Luciana Chain ; Chagas, Pablo F. das; Correa, Carolina Alves Pereira ; Baroni, Mirella; Silva, Keteryne Rodrigues da ; Nagano, Luís Fernando Peinado ; Borges, Kleiton S; Queiroz, Rosane Gomes de Paula; Tone, Luiz Gonzaga ; Scrideli, Carlos Alberto
Source: Journal of Cellular Biochemistry. Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS, CARCINOMA, CÓRTEX ADRENAL, BIOMARCADORES, REGULAÇÃO NEOPLÁSICA DA EXPRESSÃO GÊNICA, ESTEROIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VERONEZ, Luciana Chain et al. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways. Journal of Cellular Biochemistry, v. 122, n. 12, p. 1925-1935, 2021Tradução . . Disponível em: https://doi.org/10.1002/jcb.30153. Acesso em: 31 out. 2024.
APA
Veronez, L. C., Chagas, P. F. das, Correa, C. A. P., Baroni, M., Silva, K. R. da, Nagano, L. F. P., et al. (2021). MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways. Journal of Cellular Biochemistry, 122( 12), 1925-1935. doi:10.1002/jcb.30153
NLM
Veronez LC, Chagas PF das, Correa CAP, Baroni M, Silva KR da, Nagano LFP, Borges KS, Queiroz RG de P, Tone LG, Scrideli CA. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways [Internet]. Journal of Cellular Biochemistry. 2021 ; 122( 12): 1925-1935.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/jcb.30153
Vancouver
Veronez LC, Chagas PF das, Correa CAP, Baroni M, Silva KR da, Nagano LFP, Borges KS, Queiroz RG de P, Tone LG, Scrideli CA. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways [Internet]. Journal of Cellular Biochemistry. 2021 ; 122( 12): 1925-1935.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/jcb.30153
Artigo de periodico
YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells (2021)
Cruzeiro, Gustavo Alencastro Veiga ; Magalhães, Taciani de Almeida; Sousa, Graziella Ribeiro de ; Silva, Ricardo Bonfim; Biagi Junior, Carlos Alberto Oliveira de ; Chagas, Pablo Ferreira das ; Queiroz, Rosane Gomes de Paula; Scrideli, Carlos Alberto ; Tone, Luiz Gonzaga ; Valera, Elvis Terci
Source: Cancers. Unidade: FMRP
Subjects: MEDULOBLASTOMA, GENÔMICA, NEOPLASIAS, BIOMARCADORES, TERAPIA COMBINADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZEIRO, Gustavo Alencastro Veiga et al. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells. Cancers, v. 13, n. 24, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13246249. Acesso em: 31 out. 2024.
APA
Cruzeiro, G. A. V., Magalhães, T. de A., Sousa, G. R. de, Silva, R. B., Biagi Junior, C. A. O. de, Chagas, P. F. das, et al. (2021). YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells. Cancers, 13( 24), 1-11. doi:10.3390/cancers13246249
NLM
Cruzeiro GAV, Magalhães T de A, Sousa GR de, Silva RB, Biagi Junior CAO de, Chagas PF das, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells [Internet]. Cancers. 2021 ; 13( 24): 1-11.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/cancers13246249
Vancouver
Cruzeiro GAV, Magalhães T de A, Sousa GR de, Silva RB, Biagi Junior CAO de, Chagas PF das, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells [Internet]. Cancers. 2021 ; 13( 24): 1-11.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/cancers13246249
Trabalho de evento-resumo periodico
Novel bioinformatics approaches for Rna analysis may reveal common promising molecular markers between three pediatric tumors (2021)
Silva, Andréa Martins da; Popolin Neto, Mário ; Paulovich, Fernando Vieira ; Salomão, Karina Bezerra; Silva, Keteryne Rodrigues da ; Veronez, Luciana Chain ; Silva Junior, Wilson Araújo da ; Valera, Elvis Terci; Scrideli, Carlos Alberto ; Tone, Luiz Gonzaga
Source: Pediatric Blood and Cancer. Conference titles: Congress of the International Society of Paediatric Oncology - SIOP. Unidades: ICMC, FMRP, FCFRP
Subjects: BIOINFORMÁTICA, APRENDIZADO COMPUTACIONAL, VISUALIZAÇÃO, BIOMARCADORES, NEOPLASIAS, MEDULOBLASTOMA, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Andréa Martins da et al. Novel bioinformatics approaches for Rna analysis may reveal common promising molecular markers between three pediatric tumors. Pediatric Blood and Cancer. Hoboken: Instituto de Ciências Matemáticas e de Computação, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.29349. Acesso em: 31 out. 2024. , 2021
APA
Silva, A. M. da, Popolin Neto, M., Paulovich, F. V., Salomão, K. B., Silva, K. R. da, Veronez, L. C., et al. (2021). Novel bioinformatics approaches for Rna analysis may reveal common promising molecular markers between three pediatric tumors. Pediatric Blood and Cancer. Hoboken: Instituto de Ciências Matemáticas e de Computação, Universidade de São Paulo. doi:10.1002/pbc.29349
NLM
Silva AM da, Popolin Neto M, Paulovich FV, Salomão KB, Silva KR da, Veronez LC, Silva Junior WA da, Valera ET, Scrideli CA, Tone LG. Novel bioinformatics approaches for Rna analysis may reveal common promising molecular markers between three pediatric tumors [Internet]. Pediatric Blood and Cancer. 2021 ; No 2021( S5): S541-542.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.29349
Vancouver
Silva AM da, Popolin Neto M, Paulovich FV, Salomão KB, Silva KR da, Veronez LC, Silva Junior WA da, Valera ET, Scrideli CA, Tone LG. Novel bioinformatics approaches for Rna analysis may reveal common promising molecular markers between three pediatric tumors [Internet]. Pediatric Blood and Cancer. 2021 ; No 2021( S5): S541-542.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.29349
Artigo de periodico
The carbonic anhydrase inhibitor E7070 sensitizes glioblastoma cells to radio and chemotherapy and reduces tumor growth (2021)
Teixeira, Silvia Aparecida; Viapiano, Mariano S.; Andrade, Augusto F.; Nandhu, Mohan S.; Pezuk, Julia Alejandra; Bidinotto, Lucas T.; Sant'Ana, Veridiana Kiill Suazo de; Serafini, Luciano Neder; Carlotti Júnior, Carlos Gilberto ; Becker, Aline P.; Tone, Luiz Gonzaga ; Scrideli, Carlos Alberto
Source: Molecular Neurobiology. Unidade: FMRP
Subjects: ANIDRASE CARBÔNICA, METABOLISMO CELULAR, NEOPLASIAS CEREBRAIS, FARMACOTERAPIA, LINHAGEM CELULAR, CICLO CELULAR, SULFONAMIDAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA, Silvia Aparecida et al. The carbonic anhydrase inhibitor E7070 sensitizes glioblastoma cells to radio and chemotherapy and reduces tumor growth. Molecular Neurobiology, v. 58, n. 9, p. 4520-4534, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12035-021-02437-3. Acesso em: 31 out. 2024.
APA
Teixeira, S. A., Viapiano, M. S., Andrade, A. F., Nandhu, M. S., Pezuk, J. A., Bidinotto, L. T., et al. (2021). The carbonic anhydrase inhibitor E7070 sensitizes glioblastoma cells to radio and chemotherapy and reduces tumor growth. Molecular Neurobiology, 58( 9), 4520-4534. doi:10.1007/s12035-021-02437-3
NLM
Teixeira SA, Viapiano MS, Andrade AF, Nandhu MS, Pezuk JA, Bidinotto LT, Sant'Ana VKS de, Serafini LN, Carlotti Júnior CG, Becker AP, Tone LG, Scrideli CA. The carbonic anhydrase inhibitor E7070 sensitizes glioblastoma cells to radio and chemotherapy and reduces tumor growth [Internet]. Molecular Neurobiology. 2021 ; 58( 9): 4520-4534.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12035-021-02437-3
Vancouver
Teixeira SA, Viapiano MS, Andrade AF, Nandhu MS, Pezuk JA, Bidinotto LT, Sant'Ana VKS de, Serafini LN, Carlotti Júnior CG, Becker AP, Tone LG, Scrideli CA. The carbonic anhydrase inhibitor E7070 sensitizes glioblastoma cells to radio and chemotherapy and reduces tumor growth [Internet]. Molecular Neurobiology. 2021 ; 58( 9): 4520-4534.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12035-021-02437-3
Artigo de periodico
A coordinated approach for the assessment of molecular subgroups in pediatric ependymomas using low-cost methods (2021)
Sousa, Graziella Ribeiro de ; Lira, Régia Caroline Peixoto ; Magalhães, Taciani de Almeida ; Silva, Keteryne Rodrigues da ; Nagano, Luís Fernando Peinado ; Saggioro, Fabiano Pinto ; Baroni, Mirella; Marie, Suely Kazue Nagahashi ; Oba-Shinjo, Sueli Mieko; Brandelise, Silvia; Queiroz, Rosane Gomes de Paula; Annichini, María Sol Brassesco ; Scrideli, Carlos Alberto ; Tone, Luiz Gonzaga ; Valera, Elvis Terci
Source: Journal of Molecular Medicine. Unidades: FMRP, FM, FFCLRP
Subjects: MOLÉCULA, PEDIATRIA, SISTEMA NERVOSO CENTRAL, CÉREBRO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Graziella Ribeiro de et al. A coordinated approach for the assessment of molecular subgroups in pediatric ependymomas using low-cost methods. Journal of Molecular Medicine, v. 99, n. 8, p. 1101-1113, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00109-021-02074-2. Acesso em: 31 out. 2024.
APA
Sousa, G. R. de, Lira, R. C. P., Magalhães, T. de A., Silva, K. R. da, Nagano, L. F. P., Saggioro, F. P., et al. (2021). A coordinated approach for the assessment of molecular subgroups in pediatric ependymomas using low-cost methods. Journal of Molecular Medicine, 99( 8), 1101-1113. doi:10.1007/s00109-021-02074-2
NLM
Sousa GR de, Lira RCP, Magalhães T de A, Silva KR da, Nagano LFP, Saggioro FP, Baroni M, Marie SKN, Oba-Shinjo SM, Brandelise S, Queiroz RG de P, Annichini MSB, Scrideli CA, Tone LG, Valera ET. A coordinated approach for the assessment of molecular subgroups in pediatric ependymomas using low-cost methods [Internet]. Journal of Molecular Medicine. 2021 ; 99( 8): 1101-1113.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s00109-021-02074-2
Vancouver
Sousa GR de, Lira RCP, Magalhães T de A, Silva KR da, Nagano LFP, Saggioro FP, Baroni M, Marie SKN, Oba-Shinjo SM, Brandelise S, Queiroz RG de P, Annichini MSB, Scrideli CA, Tone LG, Valera ET. A coordinated approach for the assessment of molecular subgroups in pediatric ependymomas using low-cost methods [Internet]. Journal of Molecular Medicine. 2021 ; 99( 8): 1101-1113.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s00109-021-02074-2
Trabalho de evento-resumo periodico
Tumor DNA methylation profiling as a prognostic marker for pediatric patients with adrenocortical tumors (2021)
Bueno, Ana Carolina; Silva Júnior, Rui M. P. da; Stecchini, Mônica F.; Gutiérrez, Junier M.; Cardinalli, Izilda A.; Scrideli, Carlos Alberto; Junqueira, Thais; Molina, Carlos Augusto Fernandes ; Ramalho, Fernando Silva ; Tucci, Silvio; Coeli-Lacchini, Fernanda B.; Moreira, Ayrton Custódio; Ramalho, Leandra Naíra Zambelli; Brandalise, Silvia Regina; Yunes, José A.; Castro, Margaret de ; Vêncio, Ricardo Zorzetto Nicoliello; Antonini, Sonir Roberto Rauber
Source: Hormone Research In Paediatric. Conference titles: Annual Meeting of the European Society for Paediatric Endocrinology (ESPE 2021 Online). Unidades: FMRP, FFCLRP
Subjects: DNA, PACIENTES, PEDIATRIA, CARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUENO, Ana Carolina et al. Tumor DNA methylation profiling as a prognostic marker for pediatric patients with adrenocortical tumors. Hormone Research In Paediatric. Basel: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1159/000518849. Acesso em: 31 out. 2024. , 2021
APA
Bueno, A. C., Silva Júnior, R. M. P. da, Stecchini, M. F., Gutiérrez, J. M., Cardinalli, I. A., Scrideli, C. A., et al. (2021). Tumor DNA methylation profiling as a prognostic marker for pediatric patients with adrenocortical tumors. Hormone Research In Paediatric. Basel: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1159/000518849
NLM
Bueno AC, Silva Júnior RMP da, Stecchini MF, Gutiérrez JM, Cardinalli IA, Scrideli CA, Junqueira T, Molina CAF, Ramalho FS, Tucci S, Coeli-Lacchini FB, Moreira AC, Ramalho LNZ, Brandalise SR, Yunes JA, Castro M de, Vêncio RZN, Antonini SRR. Tumor DNA methylation profiling as a prognostic marker for pediatric patients with adrenocortical tumors [Internet]. Hormone Research In Paediatric. 2021 ; 94 29.[citado 2024 out. 31 ] Available from: https://doi.org/10.1159/000518849
Vancouver
Bueno AC, Silva Júnior RMP da, Stecchini MF, Gutiérrez JM, Cardinalli IA, Scrideli CA, Junqueira T, Molina CAF, Ramalho FS, Tucci S, Coeli-Lacchini FB, Moreira AC, Ramalho LNZ, Brandalise SR, Yunes JA, Castro M de, Vêncio RZN, Antonini SRR. Tumor DNA methylation profiling as a prognostic marker for pediatric patients with adrenocortical tumors [Internet]. Hormone Research In Paediatric. 2021 ; 94 29.[citado 2024 out. 31 ] Available from: https://doi.org/10.1159/000518849
Artigo de periodico
Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia (2021)
Chagas, Pablo Ferreira das ; Sousa, Graziella Ribeiro de ; Kodama, Márcio Hideki; Biagi Junior, Carlos Alberto Oliveira de ; Yunes, Jose Andres ; Brandalise, Silvia Regina; Calin, George Adrian; Tone, Luiz Gonzaga ; Scrideli, Carlos Alberto ; Oliveira, Jaqueline Carvalho de
Source: Hematology, Transfusion and Cell Therapy. Unidade: FMRP
Subjects: RNA, LEUCEMIA, LINFOMA, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAGAS, Pablo Ferreira das et al. Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia. Hematology, Transfusion and Cell Therapy, v. 43, n. 1, p. 28-34, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2019.12.003. Acesso em: 31 out. 2024.
APA
Chagas, P. F. das, Sousa, G. R. de, Kodama, M. H., Biagi Junior, C. A. O. de, Yunes, J. A., Brandalise, S. R., et al. (2021). Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia. Hematology, Transfusion and Cell Therapy, 43( 1), 28-34. doi:10.1016/j.htct.2019.12.003
NLM
Chagas PF das, Sousa GR de, Kodama MH, Biagi Junior CAO de, Yunes JA, Brandalise SR, Calin GA, Tone LG, Scrideli CA, Oliveira JC de. Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43( 1): 28-34.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.htct.2019.12.003
Vancouver
Chagas PF das, Sousa GR de, Kodama MH, Biagi Junior CAO de, Yunes JA, Brandalise SR, Calin GA, Tone LG, Scrideli CA, Oliveira JC de. Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43( 1): 28-34.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.htct.2019.12.003
Trabalho de evento-resumo periodico
Microrna expression profile identifies subgroups of pediatric adrenocortical tumors with different clinical outcomes (2021)
Veronez, Luciana Chain ; Correa, Carolina Alves Pereira ; Fedatto, Paola Fernanda ; Lira, Régia Caroline Peixoto ; Baroni, Mirella; Silva, Keteryne Rodrigues da ; Santos, Paula; Antonio, David Santos Marco; Queiroz, Rosane de Paula Silva; Antonini, Sonir Roberto Rauber ; Tucci Júnior, Silvio ; Neder, Luciano ; Yunes, José Andres; Brandalise, Silvia Regina; Panepucci, Rodrigo Alexandre; Tone, Luiz Gonzaga ; Scrideli, Carlos Alberto
Source: Pediatric Blood & Cancer. Conference titles: Congress of the International Society of Paediatric Oncology (SIOP). Unidades: FMRP, FCFRP
Subjects: PERFILAÇÃO DA EXPRESSÃO GÊNICA, MICRORNAS, NEOPLASIAS DAS GLÂNDULAS SUPRARRENAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VERONEZ, Luciana Chain et al. Microrna expression profile identifies subgroups of pediatric adrenocortical tumors with different clinical outcomes. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.29349. Acesso em: 31 out. 2024. , 2021
APA
Veronez, L. C., Correa, C. A. P., Fedatto, P. F., Lira, R. C. P., Baroni, M., Silva, K. R. da, et al. (2021). Microrna expression profile identifies subgroups of pediatric adrenocortical tumors with different clinical outcomes. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/pbc.29349
NLM
Veronez LC, Correa CAP, Fedatto PF, Lira RCP, Baroni M, Silva KR da, Santos P, Antonio DSM, Queiroz R de PS, Antonini SRR, Tucci Júnior S, Neder L, Yunes JA, Brandalise SR, Panepucci RA, Tone LG, Scrideli CA. Microrna expression profile identifies subgroups of pediatric adrenocortical tumors with different clinical outcomes [Internet]. Pediatric Blood & Cancer. 2021 ; 68 284-285.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.29349
Vancouver
Veronez LC, Correa CAP, Fedatto PF, Lira RCP, Baroni M, Silva KR da, Santos P, Antonio DSM, Queiroz R de PS, Antonini SRR, Tucci Júnior S, Neder L, Yunes JA, Brandalise SR, Panepucci RA, Tone LG, Scrideli CA. Microrna expression profile identifies subgroups of pediatric adrenocortical tumors with different clinical outcomes [Internet]. Pediatric Blood & Cancer. 2021 ; 68 284-285.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.29349
Trabalho de evento-resumo periodico
Differentially expressed-aberrantly methylated HUB genes in medulloblastoma SHH (2021)
Xavier, Karina Bezerra Salomão; Nagano, Luís Fernando Peinado ; Sousa, Graziella Ribeiro de ; Silva, Ricardo Bonfim; Baldissera, Gabriel Carlos; Scrideli, Carlos Alberto ; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Conference titles: Congress of the International Societyof Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: MEDULOBLASTOMA, METILAÇÃO DE DNA, EXPRESSÃO FACIAL, GENOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
XAVIER, Karina Bezerra Salomão et al. Differentially expressed-aberrantly methylated HUB genes in medulloblastoma SHH. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.29349. Acesso em: 31 out. 2024. , 2021
APA
Xavier, K. B. S., Nagano, L. F. P., Sousa, G. R. de, Silva, R. B., Baldissera, G. C., Scrideli, C. A., & Tone, L. G. (2021). Differentially expressed-aberrantly methylated HUB genes in medulloblastoma SHH. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/pbc.29349
NLM
Xavier KBS, Nagano LFP, Sousa GR de, Silva RB, Baldissera GC, Scrideli CA, Tone LG. Differentially expressed-aberrantly methylated HUB genes in medulloblastoma SHH [Internet]. Pediatric Blood & Cancer. 2021 ; 68( S5): S311.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.29349
Vancouver
Xavier KBS, Nagano LFP, Sousa GR de, Silva RB, Baldissera GC, Scrideli CA, Tone LG. Differentially expressed-aberrantly methylated HUB genes in medulloblastoma SHH [Internet]. Pediatric Blood & Cancer. 2021 ; 68( S5): S311.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/pbc.29349
Artigo de periodico
Arsenic Trioxide exerts cytotoxic and radiosensitizing effects in pediatric Medulloblastoma cell lines of SHH Subgroup (2020)
Klinger, Paulo Henrique dos Santos ; Delsin, Lara Elis Alberici; Cruzeiro, Gustavo Alencastro Veiga ; Andrade, Augusto Faria; Lira, Régia Caroline Peixoto ; Andrade, Pamela Viani de ; Chagas, Pablo Ferreira das ; Queiroz, Rosane Gomes de Paula; Trevisan, Felipe Amstalden; Oliveira, Ricardo Santos de ; Scrideli, Carlos Alberto ; Tone, Luiz Gonzaga ; Valera, Elvis Terci
Source: Scientific Reports. Unidade: FMRP
Subjects: APOPTOSE, LINHAGEM CELULAR, TRIAGEM TOXICOLÓGICA, MEDULOBLASTOMA, QUIMIOTERAPIA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KLINGER, Paulo Henrique dos Santos et al. Arsenic Trioxide exerts cytotoxic and radiosensitizing effects in pediatric Medulloblastoma cell lines of SHH Subgroup. Scientific Reports, v. 10, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-63808-9. Acesso em: 31 out. 2024.
APA
Klinger, P. H. dos S., Delsin, L. E. A., Cruzeiro, G. A. V., Andrade, A. F., Lira, R. C. P., Andrade, P. V. de, et al. (2020). Arsenic Trioxide exerts cytotoxic and radiosensitizing effects in pediatric Medulloblastoma cell lines of SHH Subgroup. Scientific Reports, 10. doi:10.1038/s41598-020-63808-9
NLM
Klinger PH dos S, Delsin LEA, Cruzeiro GAV, Andrade AF, Lira RCP, Andrade PV de, Chagas PF das, Queiroz RG de P, Trevisan FA, Oliveira RS de, Scrideli CA, Tone LG, Valera ET. Arsenic Trioxide exerts cytotoxic and radiosensitizing effects in pediatric Medulloblastoma cell lines of SHH Subgroup [Internet]. Scientific Reports. 2020 ; 10[citado 2024 out. 31 ] Available from: https://doi.org/10.1038/s41598-020-63808-9
Vancouver
Klinger PH dos S, Delsin LEA, Cruzeiro GAV, Andrade AF, Lira RCP, Andrade PV de, Chagas PF das, Queiroz RG de P, Trevisan FA, Oliveira RS de, Scrideli CA, Tone LG, Valera ET. Arsenic Trioxide exerts cytotoxic and radiosensitizing effects in pediatric Medulloblastoma cell lines of SHH Subgroup [Internet]. Scientific Reports. 2020 ; 10[citado 2024 out. 31 ] Available from: https://doi.org/10.1038/s41598-020-63808-9
Artigo de periodico
microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma (2020)
Roberto, Gabriela Molinari; Lira, Régia Caroline ; Delsin, Lara Elis Alberici; Vieira, Gabriela Maciel ; Silva, Marcela de Oliveira; Hakime, Rodrigo Guedes; Yamashita, Mauricio Eiji de Almeida Santos; Engel, Edgard Eduard ; Scrideli, Carlos Alberto ; Tone, Luiz Gonzaga ; Annichini, María Sol Brassesco
Source: Pathology & Oncology Research. Unidades: SVOI, FMRP, FFCLRP
Subjects: OSTEOSSARCOMA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROBERTO, Gabriela Molinari et al. microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma. Pathology & Oncology Research, v. 26, n. 2, p. 877-883, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12253-019-00633-0. Acesso em: 31 out. 2024.
APA
Roberto, G. M., Lira, R. C., Delsin, L. E. A., Vieira, G. M., Silva, M. de O., Hakime, R. G., et al. (2020). microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma. Pathology & Oncology Research, 26( 2), 877-883. doi:10.1007/s12253-019-00633-0
NLM
Roberto GM, Lira RC, Delsin LEA, Vieira GM, Silva M de O, Hakime RG, Yamashita ME de AS, Engel EE, Scrideli CA, Tone LG, Annichini MSB. microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma [Internet]. Pathology & Oncology Research. 2020 ; 26( 2): 877-883.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12253-019-00633-0
Vancouver
Roberto GM, Lira RC, Delsin LEA, Vieira GM, Silva M de O, Hakime RG, Yamashita ME de AS, Engel EE, Scrideli CA, Tone LG, Annichini MSB. microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma [Internet]. Pathology & Oncology Research. 2020 ; 26( 2): 877-883.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12253-019-00633-0
Artigo de periodico
The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma (2020)
Magalhães, Taciani de Almeida ; Borges, Kleiton Silva ; Sousa, Graziella Ribeiro de ; Brandalise, Silvia Regina; Seidinger, Ana Luiza; Scrideli, Carlos Alberto ; Shinjo, Sueli Mieko Oba ; Yunes, Jose Andres ; Tone, Luiz Gonzaga
Source: Neurological Sciences. Unidades: FMRP, FM
Subjects: DOENÇAS CEREBRAIS, PROTEÍNAS DO TECIDO NERVOSO, NEOPLASIAS CEREBRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAGALHÃES, Taciani de Almeida et al. The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma. Neurological Sciences, v. 41, n. 3, p. 691-694, 2020Tradução . . Disponível em: https://doi.org/10.1007/s10072-019-04112-x. Acesso em: 31 out. 2024.
APA
Magalhães, T. de A., Borges, K. S., Sousa, G. R. de, Brandalise, S. R., Seidinger, A. L., Scrideli, C. A., et al. (2020). The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma. Neurological Sciences, 41( 3), 691-694. doi:10.1007/s10072-019-04112-x
NLM
Magalhães T de A, Borges KS, Sousa GR de, Brandalise SR, Seidinger AL, Scrideli CA, Shinjo SMO, Yunes JA, Tone LG. The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma [Internet]. Neurological Sciences. 2020 ; 41( 3): 691-694.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s10072-019-04112-x
Vancouver
Magalhães T de A, Borges KS, Sousa GR de, Brandalise SR, Seidinger AL, Scrideli CA, Shinjo SMO, Yunes JA, Tone LG. The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma [Internet]. Neurological Sciences. 2020 ; 41( 3): 691-694.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s10072-019-04112-x

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration